Literature DB >> 2448418

Analysis of serotype-specific neutralization epitopes on VP7 of human rotavirus by the use of neutralizing monoclonal antibodies and antigenic variants.

Y Morita1, K Taniguchi, T Urasawa, S Urasawa.   

Abstract

We analysed serotype-specific antigens of human rotavirus (HRV) by the use of neutralizing monoclonal antibodies (N-MAbs). The reactivity patterns of 12 serotype-specific N-MAbs against 15 HRV strains in a neutralization test revealed great intraserotypic antigenic variation especially those belonging to serotypes 2,3 and 4. On the basis of the protein specificity of the antibodies examined, it was suggested that whereas serotype 2-specific neutralization epitopes were present on both VP3 and VP7 outer capsid proteins, serotype 1-, 3- and 4-specific neutralization epitopes were located on VP7. Serotype-specific neutralization epitopes on VP7 of the serotype 1 HRV KU strain were analysed further using mutants of the KU strain resistant to different serotype 1-specific N-MAbs. The result suggested the presence of at least five operationally overlapping neutralization epitopes on VP7 of the KU strain, which collectively constituted a single large neutralization domain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2448418     DOI: 10.1099/0022-1317-69-2-451

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  Isolation of human monoclonal antibodies that neutralize human rotavirus.

Authors:  Kyoko Higo-Moriguchi; Yasushi Akahori; Yoshitaka Iba; Yoshikazu Kurosawa; Koki Taniguchi
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

2.  Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3.

Authors:  N Kobayashi; K Taniguchi; S Urasawa
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Epidemiology of rotavirus serotypes in Melbourne, Australia, from 1973 to 1989.

Authors:  R F Bishop; L E Unicomb; G L Barnes
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

4.  Reverse genetics system for introduction of site-specific mutations into the double-stranded RNA genome of infectious rotavirus.

Authors:  Satoshi Komoto; Jun Sasaki; Koki Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

5.  Preparation and characterization of a neutralizing monoclonal antibody directed to VP4 of rotavirus strain K8 which has unique VP4 neutralization epitopes.

Authors:  N Kobayashi; K Taniguchi; T Urasawa; S Urasawa
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

6.  Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens.

Authors:  V Gouvea; R I Glass; P Woods; K Taniguchi; H F Clark; B Forrester; Z Y Fang
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

7.  Characterization of monoclonal antibodies to human group B rotavirus and their use in an antigen detection enzyme-linked immunosorbent assay.

Authors:  J W Burns; S K Welch; S Nakata; M K Estes
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

8.  Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies.

Authors:  K Taniguchi; Y Hoshino; K Nishikawa; K Y Green; W L Maloy; Y Morita; S Urasawa; A Z Kapikian; R M Chanock; M Gorziglia
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

9.  Identification of feline- and canine-like rotaviruses isolated from humans by restriction fragment length polymorphism assay.

Authors:  A Vonsover; I Shif; I Silberstein; H Rudich; Y Aboudy; E Mendelson; L Shulman; T Nakagomi; O Nakagomi
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

10.  Characterization of the neutralizing epitopes of VP7 of the Gottfried strain of porcine rotavirus.

Authors:  S Y Kang; D A Benfield; M Gorziglia; L J Saif
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.